Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Kidney fibrosis is mediated by GARP-restricted TGF-β activation in fibroblasts
Yintong Chen, Weiwei Xu, Jieli Yu, Pei Deng, Nianping Liu, Yinyin Li, Hui Zhou, Hong Zhou, Jianchuan Wang, Bo Zhao, Florian Winau, Fan Fan Hou, Yu Hu
Yintong Chen, Weiwei Xu, Jieli Yu, Pei Deng, Nianping Liu, Yinyin Li, Hui Zhou, Hong Zhou, Jianchuan Wang, Bo Zhao, Florian Winau, Fan Fan Hou, Yu Hu
View: Text | PDF
Research Article Nephrology Public Health

Kidney fibrosis is mediated by GARP-restricted TGF-β activation in fibroblasts

  • Text
  • PDF
Abstract

TGF-β is a central driver of kidney fibrosis, a common pathological hallmark of chronic kidney disease (CKD). Initiation of TGF-β signaling requires not only its synthesis but also the conversion of latent TGF-β to its bioactive form. However, the mechanisms governing TGF-β activation in the kidney and their contribution to kidney fibrosis remain poorly understood. Glycoprotein A repetitions predominant (GARP) anchors latent TGF-β on the cell surface and facilitates its bioactive release. Here, we show that GARP-mediated TGF-β activation promotes kidney fibrosis. GARP was upregulated in both human and mouse CKD kidneys, predominantly in fibroblasts, and was induced by TNF in an NF-κB–dependent fashion. In multiple mouse models of kidney fibrosis, either global or fibroblast-specific deletion of GARP markedly reduced fibrosis. Mechanistically, GARP enables sustained production of active TGF-β, thereby amplifying fibroblast stimulation. Deletion of GARP in kidney fibroblasts lowered active TGF-β levels and attenuated fibroblast activation, whereas GARP overexpression enhanced TGF-β signaling. Notably, tamoxifen-induced deletion of GARP after fibrosis onset attenuated kidney fibrosis. Together, our findings identify GARP-mediated release of active TGF-β as a critical step in sustaining fibroblast activation during kidney fibrosis and highlight GARP as a promising therapeutic target for CKD.

Authors

Yintong Chen, Weiwei Xu, Jieli Yu, Pei Deng, Nianping Liu, Yinyin Li, Hui Zhou, Hong Zhou, Jianchuan Wang, Bo Zhao, Florian Winau, Fan Fan Hou, Yu Hu

×

Figure 4

Fibroblasts and TGF-β signaling orchestrate fibrosis progression.

Options: View larger image (or click on image) Download as PowerPoint
Fibroblasts and TGF-β signaling orchestrate fibrosis progression.
(A) Un...
(A) Uniform Manifold Approximation and Projection (UMAP) embeddings of the integrated sc/snRNA-seq dataset from CKD patients and control samples (GSE183279), colored by ECM score (left), group information (right top) and cell types (right bottom). FIB, fibroblast; NEU, neural cell; VSM/P, vascular smooth muscle cell or pericyte; DTL, descending thin limb cell; PEC, parietal epithelial cells; POD, podocyte; ATL, ascending thin limbs; TAL, thick ascending limb; PT, proximal tubule; DCT, distal convoluted tubule; PC, principal cell; CNT, connecting tubule; EC, endothelial cells; IC, intercalated cells; PapE, papillary tip epithelial cells abutting the calyx; IMM, immune cells. (B) Heatmap showing the collagen score, glycoprotein score, and proteoglycan score across cell types, which collectively form the ECM score. (C) Heatmap showing the TGF-β score across the cell types. (D) Bar plots of representative biological pathways enriched in fibroblasts defined by differentially expressed genes (DEGs). (E) Gene set enrichment analysis (GSEA) of fibroblasts for KEGG TGF-β signaling (left). The table (right) lists the normalized enrichment scores (NES) for the top 5 cell types ranked by ECM scores. (F) The TGF-β score, ECM score, Fibroblast score, and LRRC32 expression in the 10× Visium data of control and CKD samples. Each score shares the same threshold in the color bar for comparison. (G) Pairwise correlations of TGF-β score, ECM score, and fibroblast score in CKD Visium data. P values were calculated using F-statistics from ordinary least-squares models, with the error band representing the 95% confidence interval.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts